FDA Warning Letter — Hangzhou Glamcos Biotech Co., Ltd.
The FDA took a Warning Letter action against Hangzhou Glamcos Biotech Co., Ltd. on Oct 7, 2024 (Hangzhou, China). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- Hangzhou Glamcos Biotech Co., Ltd.
- Date
- Oct 7, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Hangzhou (China)